SCHEMBL4558382

SCHEMBL4558382

c1cc(N2CCNCC2)c2[nH]cnc2n1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 8/20 0.49
ADRB2 P07550 4/20 0.49
HTR6 P50406 1/20 0.45
ROCK2 O75116 1/20 0.45
ROCK1 Q13464 1/20 0.45
CDC42BPB Q9Y5S2 1/20 0.45
PLD1 Q13393 1/20 0.43
METAP2 P50579 1/20 0.43
SRC P12931 2/20 0.42
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
SLC6A4 P31645 1/20 0.42
RECQL P46063 1/20 0.42
HTR7 P34969 1/20 0.41
TP53 P04637 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31309667 0.83 CHEK1 (0.57) ROCK2ROCK1CDC42BPBSRCMAPK1
SCHEMBL3289568 0.75 HTR2A (0.50) NCF1ADRB2HTR6HTR2AHTR2C
SCHEMBL1030420 0.72 HTT (0.76) SRCRECQLTP53MAPK1HTT
SCHEMBL13391271 0.71 NCF1 (0.55) NCF1ADRB2HTR6ROCK2ROCK1
SCHEMBL1537943 0.71 NCF1 (0.48) NCF1ADRB2HTR6HTR2AHTR2C
Hydrochloric Acid SCHEMBL1967814 0.70 NCF1 (0.54) NCF1ADRB2HTR6ROCK2ROCK1
SCHEMBL4178410 0.68 NCF1 (0.52) NCF1ADRB2HTR6HTR2AHTR2C
SCHEMBL2799562 0.68 AKT2 (0.67) NCF1ADRB2HTR6ROCK2ROCK1
Hydrochloric Acid SCHEMBL2800609 0.67 AKT2 (0.65) NCF1ADRB2HTR6ROCK2ROCK1
SCHEMBL6070124 0.67 SRC (0.56) SRCHTR2CTP53MAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534796-B2 Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor WYETH (US) 2009-05-19 US claimed
US-20060189617-A1 Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor WYETH (US) 2006-08-24 US claimed
WO-2026101698-A1 HEPCIDIN MIMETIC COMPOUNDS AND USES THEREOF PROTAGONIST THERAPEUTICS, INC. (US) 2026-05-15 WO disclosed
US-7534796-B2 Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor WYETH (US) 2009-05-19 US disclosed
US-20060189617-A1 Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor WYETH (US) 2006-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189617-A1 Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor GNRHR, PRLHR, FSHR NCF1 3715/4885ADRB2 504/4885HTR6 380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.